Geron to Host Virtual Investor Event on June 14, 2023
FOSTER CITY, Calif. , June 06 /Businesswire/ - Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, will host a virtual investor event on Wednesday, June 14, 2023 at 8:00 a.m. Eastern Time.
Topics to be covered at the event include:
Joining Geron’s management team during the presentation and live question and answer session are physician key opinion leaders and investigators of Geron clinical trials:
A live webcast of the event and related presentation will be available on the Company’s website at www.geron.com/investors/events. An archive of the webcast will be available on the Company’s website for 30 days.
About Geron
Geron is a late-stage biopharmaceutical company pursuing therapies with the potential to extend and enrich the lives of patients living with hematologic malignancies. Its investigational first-in-class telomerase inhibitor, imetelstat, harnesses Nobel Prize winning science in a treatment that may alter the underlying course of these diseases. To learn more, visit http://www.geron.com/or follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230606005958/en/